In addition, PCOS phenotypes; ovarian volume, AFC, total testosterone, FAI, LH and DHEA-S were significantly higher in T2DM patients compared to NGT and IGT PCO subgroups. This evidence concerns the gene PLOD1 and polycystic ovary syndrome.